Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival
This article is from
The Cancer Letter
archive.
Vol. 36 No. 10 | October 25, 2013
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Urologists support Approval Of Il-2 for Kidney Cancer
February 1, 1991
TCL Archive
Celgene Signs CRADA With NCI For Development Of CDC-501.
June 30, 2000
TCL Archive
NCI Launches NCORP with 53 Grants Totaling $465 Million
August 8, 2014
TCL Archive
NCI Sets Rules For Omics Studies
October 18, 2013
TCL Archive
Pertuzumab Delays Progression In HER2-Positive Breast Cancer
August 26, 2011
TCL Archive
Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion
August 8, 1980
